99 related articles for article (PubMed ID: 10526448)
1. [A case report of interferon-associated retinopathy].
Sobolewski P; Lapiński T
Klin Oczna; 1999; 101(3):213-6. PubMed ID: 10526448
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C and interferon-associated retinopathy: a case report.
Van Wie AM
Optometry; 2011 Dec; 82(12):739-43. PubMed ID: 22108545
[TBL] [Abstract][Full Text] [Related]
3. Interferon associated retinopathy.
Khan H; Hamid K; Feroze AH
J Pak Med Assoc; 2008 Jan; 58(1):48-9. PubMed ID: 18297981
[TBL] [Abstract][Full Text] [Related]
4. Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
Moisseiev E; Goldenberg D; Kurtz S
Ophthalmic Surg Lasers Imaging; 2011 Sep; 42 Online():e91-3. PubMed ID: 21899250
[TBL] [Abstract][Full Text] [Related]
5. [Ocular findings in hepatitis C patients treated with interferon].
Mrugacz M; Lebensztejn D
Klin Oczna; 2010; 112(7-9):253-6. PubMed ID: 21121130
[TBL] [Abstract][Full Text] [Related]
6. Interferon induced glomerular disease in a patient with chronic hepatitis C.
Suresh RL; Suryati Y; Merican I
Med J Malaysia; 2003 Oct; 58(4):594-6. PubMed ID: 15190636
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
8. Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.
Oishi A; Miyamoto K; Kashii S; Yoshimura N
Br J Ophthalmol; 2005 Nov; 89(11):1542-3. PubMed ID: 16234478
[No Abstract] [Full Text] [Related]
9. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
Sidhu-Malik NK; Kaplan AL
J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
[TBL] [Abstract][Full Text] [Related]
10. [Interferon-associated retinopathy].
Hararda T; Fukami H; Takeuchi T; Niwa T; Majima Y
Klin Monbl Augenheilkd; 1995 Nov; 207(5):302-4. PubMed ID: 8587306
[TBL] [Abstract][Full Text] [Related]
11. [Complications in interferon therapy for chronic hepatitis C].
Arase Y
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):519-22. PubMed ID: 15359854
[No Abstract] [Full Text] [Related]
12. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
Berk DR; Mallory SB; Keeffe EB; Ahmed A
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):142-51. PubMed ID: 16919505
[TBL] [Abstract][Full Text] [Related]
13. [Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon].
Sarrecchia C; Niutta P; Testore GP; Sordillo P; Proietti F; Andreoni M
Recenti Prog Med; 2001 May; 92(5):336-9. PubMed ID: 11413892
[TBL] [Abstract][Full Text] [Related]
14. Should we investigate retinopathy in chronic hepatitis C patients receiving treatment with interferon?
Aoufi Rabih S; Alfaya Muñoz LB; Fidalgo Broncano A; Villanueva Hernández R; González Carro P; Pérez Roldán F
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):242-3. PubMed ID: 24366452
[No Abstract] [Full Text] [Related]
15. Chronic hepatitis C, depression and interferon.
Horsmans Y
J Hepatol; 2005 Jun; 42(6):788-9. PubMed ID: 15885347
[No Abstract] [Full Text] [Related]
16. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
Christensen UB; Krogsgaard K
Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
[No Abstract] [Full Text] [Related]
17. [The adherence in the treatment of chronic hepatitis C].
Pawłowska M; Halota W
Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
[TBL] [Abstract][Full Text] [Related]
18. Interferon-associated retinopathy and cystoid macular edema.
Tokai R; Ikeda T; Miyaura T; Sato K
Arch Ophthalmol; 2001 Jul; 119(7):1077-9. PubMed ID: 11448335
[No Abstract] [Full Text] [Related]
19. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
[TBL] [Abstract][Full Text] [Related]
20. Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C.
Xue JH; Zhu HH; Wang J; Chen Z
World J Gastroenterol; 2014 Jun; 20(23):7505-13. PubMed ID: 24966622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
